Covasc

Covasc

amlodipine

Manufacturer:

Duopharma Manufacturing (Bangi)

Distributor:

Duopharma Marketing
Concise Prescribing Info
Contents
Amlodipine besylate
Indications/Uses
1st-line treatment of HTN & myocardial ischemia whether due to fixed obstruction (stable angina) &/or vasospasm/vasoconstriction (Prinzmetal's or variant angina) of coronary vasculature.
Dosage/Direction for Use
HTN & angina Initially 5 mg once daily. Max: 10 mg.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity to dihydropyridines.
Special Precautions
Hepatic impairment. Pregnancy & lactation. Childn.
Adverse Reactions
Headache, edema, fatigue, somnolence, nausea, abdominal pain, flushing, palpitations, dizziness.
MIMS Class
ATC Classification
C08CA01 - amlodipine ; Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.
Presentation/Packing
Form
Covasc tab 10 mg
Packing/Price
3 × 10's
Form
Covasc tab 5 mg
Packing/Price
3 × 10's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in